Next Article in Journal
Entrepreneurship as Facilitator for Sustainable Development? Editorial for the Special Issue “Advances in Sustainable Entrepreneurship”
Previous Article in Journal
Acknowledgement to Reviewers of Administrative Sciences in 2015
Article Menu

Export Article

Open AccessArticle
Adm. Sci. 2016, 6(1), 3;

Is Self-Regulation Sufficient? Case of the German Transparency Code

Euro*MBA, Tongersestraat 49, Maastricht 6211 LM, The Netherlands
Parella Weinberg Partners, 20 Grafton Street, London W1S, UK
Thammasat Business School, 2 Prachan Road, Bangkok 10200, Thailand
Author to whom correspondence should be addressed.
Academic Editor: Falih M. Alsaaty
Received: 7 December 2015 / Revised: 21 January 2016 / Accepted: 15 February 2016 / Published: 23 February 2016
Full-Text   |   PDF [906 KB, uploaded 23 February 2016]   |  


The German pharmaceutical industry is stepping ahead with its implementation of a new transparency disclosure code for cooperation between pharmaceutical companies and health care professionals (HCPs) and health care organisations (HCOs). In Germany, this transparency code (“Transparenzkodex”) is applicable since January 2015, and data will be publicly available around mid-2016. No empirical work has been done that addresses the impact of the transparency code on cooperation between HCPs, HCOs and the pharmaceutical companies, including the possibilities of competitive analysis of the available data. In this paper, we interviewed experts from 11 pharmaceutical companies representing small, medium-sized as well as multinational corporations which represent 80% of the German pharmaceutical market. Besides interviews, the authors designed a game to evaluate possible financial investments in key opinion leaders. The market can be regarded as a zero sum game. By allowing public identification of such key HCPs and HCOs, the amount spent on them might increase and not decrease. In a way, the transparency code may foster more and not less spending; in our simulation game, the financial investment in marketing key HCPs and HCOs exceeded sustainable limits. View Full-Text
Keywords: marketing; pharmaceuticals; transparency code; Germany; self-regulation marketing; pharmaceuticals; transparency code; Germany; self-regulation

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Buske, K.; Jentzsch, S.; Bechter, C. Is Self-Regulation Sufficient? Case of the German Transparency Code. Adm. Sci. 2016, 6, 3.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Adm. Sci. EISSN 2076-3387 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top